Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | $103.92 | N/A | N/A | 16.68x | 19.83x | 1.07x | 36.75x | N/A | $424.00M | 8.00% | $143.00M | 2.80 | $5.03B | 8.95 | |
| NGNE | NEUROGENE INC | $33.31 | N/A | N/A | 1.05x | -4.63x | N/A | 2.53x | N/A | -$60.01M | -10.66% | $170.78M | 10.10 | $297.59M | -8.58 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $11.84 | N/A | N/A | -6.54x | N/A | 12.53x | 2.47x | N/A | -$16.65M | -2.66% | $249.93M | 4.72 | $350.14M | -4.50 | |
| CPA | COPA HOLDINGS SA | $109.36 | N/A | N/A | 8.56x | 9.76x | 1.33x | 2.17x | N/A | $541.44M | 11.78% | $2.12B | 50.48 | $6.14B | 5.71 | |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $16.17 | N/A | N/A | -6.44x | -6.47x | N/A | 4.76x | N/A | -$170.80M | -12.18% | $296.81M | 3.42 | $1.14B | -5.48 | |
| GEF | GREIF INC | $63.90 | $52.07 | 22.73% | 10.94x | N/A | 0.58x | 1.51x | 1.12x | $408.80M | 13.67% | $1.99B | 42.58 | $5.46B | 7.28 | |
| APTO | APTOSE BIOSCIENCES INC | $1.18 | N/A | N/A | -0.19x | -0.24x | N/A | 140.48x | N/A | -$45.09M | -290.93% | $137.00k | 0.01 | $12.82M | -0.27 | |
| ANNX | ANNEXON INC | $4.33 | N/A | N/A | -2.97x | -1.32x | N/A | 1.52x | N/A | -$116.47M | -21.92% | $262.41M | 2.14 | $277.96M | -2.37 | |
| ACLS | AXCELIS TECHNOLOGIES INC | $113.23 | $130.23 | -13.05% | 14.82x | N/A | 3.27x | 4.09x | 0.45x | $144.50M | 3.91% | $901.74M | 27.63 | $3.59B | 11.83 | |
| DNTH | DIANTHUS THERAPEUTICS INC | $25.63 | N/A | N/A | 6.69x | -1.42x | 291.25x | 2.02x | N/A | -$17.61M | -2.68% | $372.69M | 14.52 | $423.00M | -9.81 | |
| APGE | APOGEE THERAPEUTICS INC | $50.31 | N/A | N/A | -9.58x | N/A | N/A | 3.67x | N/A | -$96.36M | -3.82% | $801.48M | 15.97 | $2.46B | -23.82 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $20.29 | N/A | N/A | -6.28x | -13.71x | N/A | 3.51x | N/A | -$204.92M | -11.85% | $491.89M | 5.77 | $1.61B | -6.73 | |
| RRX | REGAL REXNORD CORP | $159.68 | N/A | N/A | -332.67x | N/A | 1.61x | 1.70x | N/A | $574.50M | 5.42% | $6.25B | 94.19 | $16.57B | 15.75 | |
| IMVT | IMMUNOVANT INC | $30.70 | N/A | N/A | -16.78x | -14.90x | N/A | 6.57x | N/A | -$210.56M | -4.75% | $679.34M | 4.70 | $3.77B | -15.53 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.